Provider review, September 2026
NativeMed prints the word "Passed" beside four named laboratory tests on its coenzyme page. There is no certificate, no document and no link behind any of them, and a reader who wants to see the result the page is reporting has nowhere to go.
NativeMed is not a paid partner; this link may earn a commission if that changes. Full disclosure.
The product page carries a section headed with a claim about proven, lab-tested results. It says each pharmacy in the seller's network conducts third-party testing through federally registered laboratories, that the tests cover four quality and safety markers, and that a potency test is repeated every three to six months.
Each of the four is then given a result. The word printed beside them is "Passed". The potency test's description is specific enough to be checkable in principle — it states the tolerance band the concentration must fall within.
None of it is reachable. This site extracted every link and every embedded-file attribute on the page, because certificates on sellers like this are routinely wired into a button rather than an anchor, and found none pointing at a certificate, an analysis or a PDF.
The words "certificate of analysis" do not appear on the page at all. What is published is a report of results, written by the seller, about tests nobody outside the seller can see.
A claim of third-party testing and a published certificate are different products for a reader. The first is a promise; the second is evidence. Most sellers on this roster offer neither, a few offer the first, and almost none offer the second.
This seller sits in an unusual position: it offers more detail than a promise — named tests, a stated tolerance, a stated retest interval — and still no evidence. That is more informative than silence and it is not verification.
The failure mode this creates is specific. A comparison that scored testing by counting testing language would rank this seller above one that says nothing, which is the wrong way round if what a buyer wants is a document.
This site records the claim and its unreachability as one fact rather than two, because separating them is what produces the wrong ranking.
The coenzyme's price line is unusually honest about being promotional: it says the lower figure covers the first month and then names the standing rate. Most sellers on this roster print the promotional figure and leave the standing one to be discovered.
But the same page also carries a plan grid with a three-month figure and a separate paired figure, and the seller's all-products collection shows a third arrangement with a different anchor. That is four numbers for one product across two of the seller's own pages.
None of them contradicts the others outright — they describe different plans — and none of them is labelled clearly enough that a reader could say which one applies to them without an intake.
This site records the first-month figure, states in the qualifier that it is a first-month rate, names the standing rate, and lists the other figures rather than picking one and calling it the price.
The operating company is named plainly in the terms, along with the clinical practice and a street address. Screened against the regulator's warning-letter index by company name, it returns a letter.
The letter concerns false and misleading claims, and its own text records that the review was conducted on this seller's website at this address. That is an unusually direct connection between an enforcement action and the pages a reader is looking at.
It is disclosed on the row, linked, and does not move this seller's score or position here. That is this site's standing rule and it is applied identically to every seller with a letter.
It is worth stating what the letter does not do: it does not tell a reader whether any particular sentence on the site today is one the regulator objected to. Anyone weighing it should read the letter rather than this summary of it.
NativeMed received an FDA warning letter issued June 2026. A warning letter discloses; it does not, on its own, disqualify a provider — see the trade-offs above for what this one concerned.
Trellis Vitality frames its program around body-composition tracking rather than scale weight, pairing NAD+, glutathione and tesamorelin with at-home biomarker panels and a 90-day re-test, and names its dispensing pharmacy, VialsRX in Houston, by address.
Read the full Trellis Vitality review
Trellis Vitality is not a paid partner; this link may earn a commission if that changes. Full disclosure.
Visit Trellis VitalityNo. It publishes test names, a tolerance, a retest interval and the word "Passed", and no document, link or file anywhere on the page.
No. The page labels it a first-month rate and prints the higher standing rate in the same line.
Four, across its product page and its all-products collection, describing different plans and never reconciled to each other.
Yes, over false and misleading claims, and the letter's own text records that this website was the subject of the review. It is disclosed here and does not affect the seller's score or position.
No. The operating company, the clinical practice and a street address are named; the dispensing pharmacy is not.
NativeMed is not a paid partner; this link may earn a commission if that changes. Full disclosure.